NCT07528508PHASE1RecruitingAccepts Healthy Volunteers
A Clinical Trial in Healthy Participants to Study the Effect of a Single Dose of MK-8527 on Levels of Methadone (MK-8527-020)
Merck Sharp & Dohme LLC
Start Date
5/22/2026
Completion Date
8/10/2026
Summary
The goal of this study is to learn about the effect of a study medicine called MK-8527 when taken with methadone. The study will also measure what happens to the methadone in a healthy person's body over time after MK-8527 is taken.
Eligibility Criteria
Age Range: 18 years to 65 years
Inclusion Criteria:
The main inclusion criteria include but are not limited to the following:
* Has a body-mass index (BMI) between 18 and 35 kg/m\^2
Exclusion Criteria:
The main exclusion criteria include but are not limited to the following:
* Has a history of clinically significant endocrine, gastrointestinal (GI), cardiovascular, hematological, hepatic, immunological, renal, respiratory, genitourinary, or major neurological (including stroke and chronic seizures) abnormalities or diseases
* Has a history of cancer (malignancy)
* Has a history of significant multiple and/or severe allergies (e.g., food, drug, latex allergy), or has had an anaphylactic reaction or significant intolerability (i.e., systemic allergic reaction) to prescription or nonprescription drugs or food
* Has a positive test(s) for Hepatitis B surface antigen (HBsAg), hepatitis C antibodies or human immunodeficiency virus (HIV)
Interventions
DRUG
MK-8527
DRUG
Methadone
Conditions
Healthy
Locations
Pinnacle Research Group ( Site 0002)
Anniston, Alabama 36207
United States